Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.54 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.54 |
| ▸ | NPC1 | O15118 | 5/20 | 0.53 |
| ▸ | RAB9A | P51151 | 5/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | NAMPT | P43490 | 1/20 | 0.52 |
| ▸ | CTNNB1 | P35222 | 3/20 | 0.49 |
| ▸ | WNT3A | P56704 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | NSD2 | O96028 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.46 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL20898199 | 0.98 | TAS1R3 (0.52) | TAS1R3TAS1R1NPC1RAB9ASMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL20897520 | 0.91 | TAS1R3 (0.47) | TAS1R3TAS1R1NPC1RAB9ASMN1; SMN2 | |
| Pyrrolidine SCHEMBL22442341 | 0.88 | TAS1R3 (0.45) | TAS1R3TAS1R1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL703854 | 0.85 | CTNNB1 (0.65) | NPC1RAB9ASMN1; SMN2NAMPTCTNNB1 | |
| SCHEMBL21129477 | 0.84 | TAS1R3 (0.56) | TAS1R3TAS1R1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL5783191 | 0.84 | TAS1R3 (0.52) | TAS1R3TAS1R1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL9298986 | 0.83 | CTNNB1 (0.52) | TAS1R3TAS1R1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL29948972 | 0.83 | RAB9A (0.55) | TAS1R3TAS1R1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL12173891 | 0.80 | TAS1R3 (0.59) | TAS1R3TAS1R1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL11989349 | 0.80 | TAS1R3 (0.59) | TAS1R3TAS1R1NPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118834382-A | Preparation method of intrinsic antibacterial nylon based on end capping strategy | 湘潭大学 | 2024-10-25 | — | — | CN | claimed |
| CN-111295382-B | Bridged bicyclic compounds as farnesyl ester X receptor modulators | 百时美施贵宝公司 | 2024-02-02 | — | — | CN | claimed |
| CN-117050300-A | Polylysine-based polymer adjuvant material, and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2023-11-14 | — | — | CN | claimed |
| US-20230255906-A1 | Targeting Serpin B9 in Cancer | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2023-08-17 | — | — | US | claimed |
| CN-113603886-A | Polyethyleneimine derivative and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2021-11-05 | — | — | CN | claimed |
| US-12577243-B2 | Monoacylglycerol lipase modulators | JANSSEN PHARMACEUTICA NV (BE) | 2026-03-17 | — | — | US | disclosed |
| EP-4704830-A2 | MRGPRX2 INHIBITORS AND METHODS OF USE THEREOF | Septerna, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-3856178-B1 | MONOACYLGLYCEROL LIPASE MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2026-03-11 | — | — | EP | disclosed |
| EP-4077287-B1 | EFFICIENT PROCESS FOR MAKING 6-CARBOXY BENZOXAZOLE DERIVATIVES | PFIZER IRELAND PHARMACEUTICALS UNLIMITED COMPANY (IE) | 2025-11-19 | — | — | EP | disclosed |
| EP-4077287-C0 | EFFICIENT PROCESS FOR MAKING 6-CARBOXY BENZOXAZOLE DERIVATIVES | PFIZER IRELAND PHARMACEUTICALS UNLIMITED COMPANY (IE) | 2025-11-19 | — | — | EP | disclosed |
| WO-2025122558-A1 | PYRAZINAMIDE-MIMICKING SMALL MOLECULES AS TREATMENT FOR TUBERCULOSIS | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2025-06-12 | — | — | WO | disclosed |
| CN-115135639-B | Efficient process for preparing 6-carboxybenzoxazole derivatives | 辉瑞爱尔兰制药公司 | 2025-04-01 | — | — | CN | disclosed |
| US-5747492-A | IMPROVING MEMORY; A-AMINO-3-HYDROXY-5-METHYL ISOOXAZOLE-4-PROPIONIC ACID | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-05-05 | — | — | US | disclosed |
| EP-0834311-A1 | Method for inhibiting the growth of mammalian cells | ROHM AND HAAS COMPANY (US) | 1998-04-08 | — | — | EP | disclosed |
| EP-0816348-A1 | Heterocyclic n-acetonylbenzamides and their use as fungicides | ROHM AND HAAS COMPANY (US) | 1998-01-07 | — | — | EP | disclosed |
| EP-0591786-B1 | Photosensitive composition | FUJI PHOTO FILM CO LTD (JP) | 1996-05-15 | — | — | EP | disclosed |
| EP-0651746-A1 | DRUGS THAT ENHANCE SYNAPTIC RESPONSES MEDIATED BY AMPA RECEPTORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-05-10 | — | — | EP | disclosed |
| CN-1094400-A | Heterogeneous ring compound | ZENECA LTD (GB) | 1994-11-02 | — | — | CN | disclosed |
| EP-0591786-A2 | Photosensitive composition | FUJI PHOTO FILM CO., LTD. (JP) | 1994-04-13 | — | — | EP | disclosed |
| WO-1994002475-A1 | DRUGS THAT ENHANCE SYNAPTIC RESPONSES MEDIATED BY AMPA RECEPTORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577243-B2 | Monoacylglycerol lipase modulators | MGLL, LPL, FAAH | TAS1R3 1128/4885TAS1R1 1596/4885NPC1 212/4885 |
| US-20230255906-A1 | Targeting Serpin B9 in Cancer | SERPINB10, SERPINB8, SERPINE1 | TAS1R3 3520/4885TAS1R1 3465/4885NPC1 1048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.